Kessler TM - Search Results

1

Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013.

Cotterill N, Madersbacher H, Wyndaele JJ, Apostolidis A, Drake MJ, Gajewski J, Heesakkers J, Panicker J, Radziszewski P, Sakakibara R, Sievert KD, Hamid R, Kessler TM, Emmanuel A. Cotterill N, et al. Among authors: kessler tm. Neurourol Urodyn. 2018 Jan;37(1):46-53. doi: 10.1002/nau.23289. Epub 2017 Jun 22. Neurourol Urodyn. 2018. PMID: 28640977 Review.

2

[Urodynamic phenomena in the aging bladder].

Kessler TM, Madersbacher H. Kessler TM, et al. Urologe A. 2004 May;43(5):542-6. doi: 10.1007/s00120-004-0564-z. Urologe A. 2004. PMID: 15045179 Review. German.

3

Intermittent catheterisation in older people: a valuable alternative to an indwelling catheter?

Pilloni S, Krhut J, Mair D, Madersbacher H, Kessler TM. Pilloni S, et al. Among authors: kessler tm. Age Ageing. 2005 Jan;34(1):57-60. doi: 10.1093/ageing/afh233. Epub 2004 Nov 10. Age Ageing. 2005. PMID: 15537679

4

Bilateral migration of sacral neuromodulation tined leads in a thin patient.

Kessler TM, Madersbacher H, Kiss G. Kessler TM, et al. J Urol. 2005 Jan;173(1):153-4. doi: 10.1097/01.ju.0000146480.28680.3e. J Urol. 2005. PMID: 15592061 No abstract available.

5

Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?

Kessler TM, Danuser H, Schumacher M, Studer UE, Burkhard FC. Kessler TM, et al. Neurourol Urodyn. 2005;24(3):231-6. doi: 10.1002/nau.20105. Neurourol Urodyn. 2005. PMID: 15747344 Clinical Trial.

6

Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?

Kessler TM, Madersbacher H, Kiss G. Kessler TM, et al. Eur Urol. 2005 May;47(5):660-5. doi: 10.1016/j.eururo.2004.11.005. Epub 2005 Jan 4. Eur Urol. 2005. PMID: 15826759

7

Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele.

Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H. Kessler TM, et al. Neurourol Urodyn. 2006;25(4):361-7. doi: 10.1002/nau.20230. Neurourol Urodyn. 2006. PMID: 16721816

8

Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele.

Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H. Kessler TM, et al. Neurourol Urodyn. 2006;25(7):758-62. doi: 10.1002/nau.20304. Neurourol Urodyn. 2006. PMID: 16986135

9

Safety of prolonged sacral neuromodulation tined lead testing.

Kessler TM, Burkhard FC, Madersbacher H, Kofler A, Poewe W, Kiss G. Kessler TM, et al. Curr Med Res Opin. 2008 Feb;24(2):343-7. doi: 10.1185/030079908x253555. Curr Med Res Opin. 2008. PMID: 18073008

10

Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.

Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A. Roosen A, et al. Among authors: kessler tm. Eur Urol. 2009 Jun;55(6):1440-8. doi: 10.1016/j.eururo.2008.11.009. Epub 2008 Nov 18. Eur Urol. 2009. PMID: 19054608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page